Literature DB >> 19695637

Development of a symptom score for dysfunctional elimination syndrome.

Kourosh Afshar1, Amir Mirbagheri, Heidi Scott, Andrew E MacNeily.   

Abstract

PURPOSE: Dysfunctional elimination syndrome is a heterogeneous syndrome with no widely accepted diagnostic criteria. Previously developed questionnaires provide incomplete psychometric assessment. We developed a discriminative questionnaire for diagnosing dysfunctional elimination syndrome and assessed its validity and reliability.
MATERIALS AND METHODS: A 14-item 5-point Likert scale questionnaire was devised using literature review, expert opinions and patient input. The questionnaire was administered to 62 children 4 to 16 years old (median age 8) clinically diagnosed with dysfunctional elimination syndrome by a pediatric urologist, of whom 71% were female. It was also administered to 50 healthy controls 4 to 16 years old (median age 7), of whom 66% were female. Children with structural abnormalities were excluded from study. To assess reliability 50 participants were asked to complete the questionnaire again 1 week later.
RESULTS: Median total score in cases and controls was 14 of 52 (range 4 to 30) and 6 of 52 (range 1 to 13), respectively. The difference was statistically significant (p = 0.001). Discriminant function analysis showed 80% accuracy. ROC curve showed a score of 11 as the optimum threshold with an AUC of 0.903 (95% CI 0.814-0.948). Test-retest reliability was 84.5% (p = 0.001). Factor analysis showed unloading on 4 factors, corresponding to urinary incontinence, urgency, obstructive symptoms and constipation/fecal soiling. Of participants 85% classified the questionnaire as very easy or easy to complete.
CONCLUSIONS: This new questionnaire is valid and reliable for diagnosing dysfunctional elimination syndrome. It can be used as a clinical or research instrument.

Entities:  

Mesh:

Year:  2009        PMID: 19695637     DOI: 10.1016/j.juro.2009.03.009

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Bladder and bowel dysfunction in children: An update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem.

Authors:  Joana Dos Santos; Roberto I Lopes; Martin A Koyle
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Canadian Urological Association guideline for the treatment of bladder dysfunction in children.

Authors:  Kourosh Afshar; Joana Dos Santos; Anne-Sophie Blais; Darcie Kiddoo; Nafisa Dharamsi; Mannan Wang; Maryam Noparast
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

3.  Lower Urinary Tract Symptoms in Older Children With and Without Diabetes Mellitus.

Authors:  Maryellen S Kelly; Jonathan C Routh; Leah G Davis; J Todd Purves; John S Wiener; Matthew L Maciejewski
Journal:  Clin Pediatr (Phila)       Date:  2018-08-27       Impact factor: 1.168

4.  Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.

Authors:  Beth A Drzewiecki; John C Thomas; John C Pope; Mark C Adams; John W Brock; Stacy T Tanaka
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

5.  Ambulant monitoring of bladder oxygenation and hemodynamics using wireless near-infrared spectroscopy.

Authors:  Andrew John Macnab; Babak Shadgan; Lynn Stothers; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

6.  Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old.

Authors:  Trisha M Juliano; Heidi A Stephany; Douglass B Clayton; John C Thomas; John C Pope; Mark C Adams; John W Brock; Stacy T Tanaka
Journal:  J Urol       Date:  2013-01-23       Impact factor: 7.450

7.  Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study.

Authors:  Anne-Sophie Blais; Fannie Morin; Jonathan Cloutier; Katherine Moore; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

8.  Randomized, double-blind, placebo-controlled trial of polyethylene glycol (MiraLAX®) for urinary urge symptoms.

Authors:  Nicol Corbin Bush; Anjana Shah; Theodore Barber; Mary Yang; Ira Bernstein; Warren Snodgrass
Journal:  J Pediatr Urol       Date:  2012-11-03       Impact factor: 1.830

9.  Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis.

Authors:  Ramiro J Madden-Fuentes; Mehreen Arshad; Sherry S Ross; Patrick C Seed
Journal:  Clin Ther       Date:  2015-07-29       Impact factor: 3.393

10.  Lower Urinary Tract Symptoms and Incontinence in Children with Pompe Disease.

Authors:  Divya Ajay; Erin R McNamara; Stephanie Austin; John S Wiener; Priya Kishnani
Journal:  JIMD Rep       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.